Back
Enterprise Financial Services Corp. Vs. BioMarin Pharmaceutical, Inc. Industry Stock Comparison
Sell
48
EFSC
Enterprise Financial Services Corp.
Last Price:
$55.78
Seasonality Move:
2.26%
Buy
54
BMRN
BioMarin Pharmaceutical, Inc.
Last Price:
$61.19
Seasonality Move:
5.52%
Sell
48
Enterprise Financial Services Corp. (EFSC)
is a Sell
Is Enterprise Financial Services Corp. a Buy, Sell or Hold?
-
The current Enterprise Financial Services Corp. [EFSC] share price is $55.79. The Score for EFSC is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
-
EFSC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
54
BioMarin Pharmaceutical, Inc. (BMRN)
is a Buy
Is BioMarin Pharmaceutical, Inc. a Buy, Sell or Hold?
-
The current BioMarin Pharmaceutical, Inc. [BMRN] share price is $61.15. The Score for BMRN is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
-
BMRN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
EFSC Stock Price Chart
What is Enterprise Financial Services Corp.'s stock price today?
-
The Enterprise Financial Services Corp. share price today is $55.79The current trend is moderately bullish and EFSC is experiencing slight selling pressure.
BMRN Stock Price Chart
What is BioMarin Pharmaceutical, Inc.'s stock price today?
-
The BioMarin Pharmaceutical, Inc. share price today is $61.15Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BMRN is experiencing slight buying pressure.
EFSC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.58 | Buy |
| Relative Strength Index (14 RSI): | 52.04 | Buy |
| Chaikin Money Flow: | -171705 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (53.52 - 56.58) | Buy |
| Bollinger Bands (100): | (53.74 - 59.26) | Sell |
BMRN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.19 | Buy |
| Relative Strength Index (14 RSI): | 73.39 | Buy |
| Chaikin Money Flow: | 7836963 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (52.19 - 56.01) | Buy |
| Bollinger Bands (100): | (52.65 - 57.43) | Buy |
EFSC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 56.63 | Sell |
| 20-day SMA: | 55.68 | Buy |
| 50-day SMA: | 54.54 | Buy |
| 200-day SMA: | 55.13 | Buy |
| 8-day EMA: | 56.25 | Sell |
| 20-day EMA: | 55.68 | Buy |
| 50-day EMA: | 55.42 | Buy |
| 200-day EMA: | 55.26 | Buy |
BMRN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 53.6 | Buy |
| 20-day SMA: | 54.21 | Buy |
| 50-day SMA: | 53.61 | Buy |
| 200-day SMA: | 57.94 | Buy |
| 8-day EMA: | 54.44 | Buy |
| 20-day EMA: | 53.99 | Buy |
| 50-day EMA: | 54.1 | Buy |
| 200-day EMA: | 58.28 | Buy |
Enterprise Financial Services Corp. Earnings Growth & EFSC Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.53 per share, and an increase next year of $0.26 per share.
BioMarin Pharmaceutical, Inc. Earnings Growth & BMRN Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.97 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.28 per share, and an increase next year of $1.68 per share.
Enterprise Financial Services Corp. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
BioMarin Pharmaceutical, Inc. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||